Dyne Therapeutics, Inc. (DYN) KPIs and segments

DYNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30

$17.01−0.98 (-5.45%)

Close on Nov 12, 2026Market cap $3.18BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Dyne Therapeutics's business

Coming soon

This tab will track the numbers specific to Dyne Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?